After identifying 3 neuroprotective drugs acting on different axonal pathobiologies, the researchers assessed each drug’s efficacy on percentage brain volume change among patients with secondary progressive...
Can apolipoprotein CIII plasma concentration predict whether a patient with coronary artery disease is at greater risk for experiencing ischemic stroke or a transient ischemic attack? Here are the results...
After reviewing data from 4500 MESA participants, researchers determined whether tracking cross-sectionally measured NT-proBNP over 3.2 years is related to incident dementia. Find out more about this new...
It is unclear why patients with multiple sclerosis have reduced bone mineral density. Authors of a new study investigated the factors that may cause this decrease and found several independent contributors....
Researchers investigated the effect of shift work on headache, as well as whether the association between shift work and headache could be explained by potential mediators such as perceived stress and poor...
In a new study, investigators evaluated data on more than 31,000 patients to determine whether specific antihypertensive medication classes can reduce the risk of dementia vs other classes.
For this study, the researchers evaluated whether magnetoencephalography scanning could be a valuable measure of cognitive impairment among patients with multiple sclerosis. Their findings might surprise...
The RADIANCE phase 2 study showed the effectiveness of an investigational MS therapy vs placebo, so authors of the phase 3 SUNBEAM study compared the drug’s efficacy and safety with that of intramuscular...
